GlaxoSmithKline | GSK - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.03 1 2026-03
Alcon AG 36.42 1.77 2026-03
Almirall 79.43 0.3 2025-12
Amgen 19.84 5.47 2026-03
argenx SE 32.12 10.9 2026-03
AstraZeneca 29.59 2.3 2026-03
Bayer 3.4 8.75 2026-03
Biogen 13.7 0.32 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Fresenius 15.18 0.63 2025-12
Fresenius Medical Care 6.64 2.07 2026-03
Genmab 17.14 4.39 2025-12
Gilead Sciences 17.7 2.07 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Glaxosmithkline 15.09 3.43 2026-03
GRIFOLS 10.98 5.83 2026-03
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.54 0.6 2026-03
Lonza 34.34 2.58 2025-12
Merck 12.74 7.82 2026-03
Merck 16.52 2.6 2026-03
Novartis 20.17 2.32 2026-03
Novo Nordisk 12.78 0.01 2025-12
Orion 18.52 10.02 2026-03
Pfizer 9.32 5.16 2026-03
Philips 14.32 1.33 2026-03
Recordati 17.66 7.44 2026-03
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Roche Holding 16.09 3.51 2025-12
Sanofi 11.84 0.14 2026-03
Smith & Nephew 17.63 4.2 2025-12
UCB 29.7 5.52 2025-12